CYP2C19*1 and CYP2C19*2 Polymorphism in Turkish Patients Being Diagnosed with Stable Coronary Artery Disease and Using Clopidogrel

CYP2C19*1 and CYP2C19*2 Polymorphism in Turkish Patients Being Diagnosed with Stable Coronary Artery Disease and Using Clopidogrel

Objective:The CYP2C19*1 has an entirely normal activity allele whose clopidogrel metabolism is normal. CYP2C19*2 called as non-functional alleles. In this study, we aimed to establish the CYP2C19*1 and CYP2C19*2 genotype frequencies both in Turkish patients with coronary artery disease (CAD), who us...

Descripció completa

Dades bibliogràfiques
Autors principals: Ramazan Sabırlı, Aylin Köseler, Atakan Yılmaz, İsmail Doğu Kılıç
Format: Article
Idioma:English
Publicat: Galenos Yayinevi 2021-03-01
Col·lecció:Bagcilar Medical Bulletin
Matèries:
clopidogrel metabolism
coronary artery disease
cyp2c19 polymorphism
turkish population
Accés en línia: http://behmedicalbulletin.org/archives/archive-detail/article-preview/cyp2c191-and-cyp2c192-polymorphism-in-turkish-pati/42603

Internet

http://behmedicalbulletin.org/archives/archive-detail/article-preview/cyp2c191-and-cyp2c192-polymorphism-in-turkish-pati/42603

Ítems similars